Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize data showing the relationship between early responses to oral anti–hepatitis B virus agents and future treatment outcomes
- Discuss the importance of Week 12 and 24 virologic monitoring in making on-treatment decisions for hepatitis B in patients receiving oral therapy
- Recount the on-treatment definitions of response in hepatitis B and differential management strategies based on treatment response
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.